149 related articles for article (PubMed ID: 6307105)
1. Fibrinogen interaction with platelet receptors.
Niewiarowski S; Kornecki E; Budzynski AZ; Morinelli TA; Tuszynski GP
Ann N Y Acad Sci; 1983 Jun; 408():536-55. PubMed ID: 6307105
[TBL] [Abstract][Full Text] [Related]
2. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
Kornecki E; Tuszynski GP; Niewiarowski S
J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
[TBL] [Abstract][Full Text] [Related]
4. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
Kornecki E; Tuszynski GP; Niewiarowski S
Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
[TBL] [Abstract][Full Text] [Related]
5. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
Pidard D; Frelinger AL; Bouillot C; Nurden AT
Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
[TBL] [Abstract][Full Text] [Related]
6. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
Shattil SJ; Hoxie JA; Cunningham M; Brass LF
J Biol Chem; 1985 Sep; 260(20):11107-14. PubMed ID: 2411729
[TBL] [Abstract][Full Text] [Related]
7. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets.
Kornecki E; Niewiarowski S; Morinelli TA; Kloczewiak M
J Biol Chem; 1981 Jun; 256(11):5696-701. PubMed ID: 6263888
[No Abstract] [Full Text] [Related]
8. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
9. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123).
Kornecki E; Lee H; Merlin F; Hershock D; Tuszynski GP; Niewiarowski S
Thromb Res; 1984 Apr; 34(1):35-49. PubMed ID: 6328693
[TBL] [Abstract][Full Text] [Related]
10. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
11. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
Coller BS; Peerschke EI; Scudder LE; Sullivan CA
J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
[TBL] [Abstract][Full Text] [Related]
12. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation.
Musial J; Niewiarowski S; Hershock D; Morinelli TA; Colman RW; Edmunds LH
J Lab Clin Med; 1985 Apr; 105(4):514-22. PubMed ID: 2984300
[TBL] [Abstract][Full Text] [Related]
13. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
[TBL] [Abstract][Full Text] [Related]
14. Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II.
Lee H; Nurden AT; Thomaidis A; Caen JP
Br J Haematol; 1981 May; 48(1):47-57. PubMed ID: 6454435
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
[TBL] [Abstract][Full Text] [Related]
16. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
Legrand C; Nurden AT
Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
[TBL] [Abstract][Full Text] [Related]
17. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.
Brass LF; Shattil SJ
J Clin Invest; 1984 Mar; 73(3):626-32. PubMed ID: 6231306
[TBL] [Abstract][Full Text] [Related]
18. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
[TBL] [Abstract][Full Text] [Related]
19. The platelet-fibrinogen interaction. Evidence for proximity of the A alpha chain of fibrinogen to platelet membrane glycoproteins IIb/III.
Marguerie GA; Thomas-Maison N; Ginsberg MH; Plow EF
Eur J Biochem; 1984 Feb; 139(1):5-11. PubMed ID: 6230229
[TBL] [Abstract][Full Text] [Related]
20. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.
Niewiarowski S; Budzynski AZ; Morinelli TA; Brudzynski TM; Stewart GJ
J Biol Chem; 1981 Jan; 256(2):917-25. PubMed ID: 6256372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
